Editorial Policies

Cancer Studies and Molecular Medicine – Open Journal follows strict editorial policies to ensure that published research meets high standards of scientific integrity and transparency. The editorial board is responsible for overseeing the peer review process and ensuring that all submissions are evaluated fairly, without bias. The journal’s editorial policies emphasize the importance of originality, ethical conduct, and proper citation practices. Articles are considered based on scientific merit, relevance to the journal’s scope, and adherence to ethical standards. The journal maintains a transparent review process and ensures that all editorial decisions are based solely on the quality and validity of the submitted work. The editorial board also regularly reviews and updates the journal’s policies to ensure alignment with best practices and industry standards. Ethical guidelines related to authorship, conflicts of interest, data integrity, and consent for human/animal research are integral to the journal’s editorial policies. These policies are clearly communicated to authors and reviewers, ensuring a consistent and fair approach to publication.

COPE Recommendation for Plagiarism

In line with the recommendations from the Committee on Publication Ethics (COPE), Cancer Studies and Molecular Medicine – Open Journal takes a strict stance against plagiarism. All submitted manuscripts undergo plagiarism detection using software tools to ensure that the content is original and properly attributed. Any manuscript found to have plagiarized content will be rejected, and the authors may be prohibited from submitting to the journal in the future. If plagiarism is detected after publication, the journal will issue a retraction, and a formal statement will be published. Authors are required to properly cite all sources of data, ideas, and text that are not their own and to provide clear attribution for any borrowed materials. The journal adheres to COPE’s guidelines on ethical publishing, which include transparency, fairness, and accountability in all stages of the editorial and peer review process. COPE’s approach ensures that the integrity of the published research is upheld, and it provides a framework for dealing with any ethical misconduct, including plagiarism.

Publication Ethics and Malpractice Statement

Cancer Studies and Molecular Medicine – Open Journal adheres to a comprehensive Publication Ethics and Malpractice Statement that aligns with international standards for ethical publishing. The journal is committed to ensuring the integrity of the publication process and addressing any instances of ethical misconduct. Authors are required to ensure that their work is original, properly cited, and free from any form of plagiarism. The journal has strict policies regarding the reporting of research involving human and animal subjects, which must adhere to ethical guidelines and obtain appropriate approval from ethics committees. Editors and reviewers must act impartially and maintain confidentiality throughout the peer review process. Any conflicts of interest must be disclosed, and both authors and reviewers must ensure transparency and honesty in their actions. In cases of suspected misconduct, including falsification of data, plagiarism, or breach of ethical guidelines, the journal will take appropriate corrective action, which may include retraction of articles or other disciplinary measures. The journal’s commitment to high ethical standards ensures that published research is trustworthy and of the highest scientific quality.

Peer Review Process

The peer review process at Cancer Studies and Molecular Medicine – Open Journal is designed to ensure the quality, integrity, and transparency of the research published in the journal. All submitted manuscripts undergo a rigorous, double-blind peer review process, where both the identities of the authors and reviewers are kept confidential. The journal aims to provide constructive feedback to authors, enhancing the quality of their work, while ensuring an impartial evaluation based on scientific merit. Reviewers are selected for their expertise in the field, and they are tasked with assessing the originality, methodology, data analysis, and conclusions of the study. Reviewers are also expected to identify any potential ethical concerns, such as plagiarism or conflicts of interest. The editorial board oversees the process, making final decisions on manuscript acceptance, revision, or rejection based on reviewers’ feedback. The journal is committed to timely, transparent, and fair decision-making, and strives to maintain high editorial standards. The peer review process is central to the journal’s commitment to publishing reliable and impactful research.

Advertisement Policies

Cancer Studies and Molecular Medicine – Open Journal maintains a strict policy regarding advertisements to ensure that the journal’s content is free from commercial influence. The journal does not accept unsolicited advertising or promotional material related to products, services, or organizations that could bias the content of the journal or its editorial decisions. Advertisements, if accepted, must be clearly distinguished from editorial content and must adhere to ethical standards. All advertising material will be reviewed for compliance with the journal’s standards and will not conflict with the scientific nature of the publication. Advertisements related to pharmaceutical products, medical devices, or similar areas of research must comply with the relevant regulatory standards and ethical guidelines. The journal strives to maintain the integrity of its scientific content by ensuring that advertisements do not interfere with the independence of the editorial and peer review processes. Transparency regarding advertising policies ensures that the readers can distinguish between independent research and commercial content.

Editorial Process

The editorial process at Cancer Studies and Molecular Medicine – Open Journal is designed to maintain transparency, fairness, and scientific rigor. Upon submission, manuscripts are reviewed by the editorial team for initial assessment of relevance, quality, and adherence to the journal’s guidelines. After this, the manuscript is sent out for peer review by experts in the relevant field. Reviewers provide feedback on the scientific quality, originality, and clarity of the manuscript, and may recommend revisions. The editorial board considers the reviewers' comments before making a final decision on whether the manuscript should be accepted, revised, or rejected. The journal aims to provide a timely decision and communicates with authors at each stage of the process. In case of major revisions, the manuscript is sent back to the reviewers for further evaluation. Throughout the editorial process, the integrity of the work is prioritized, with ethical considerations such as proper citation, data accuracy, and conflict of interest management being central to decision-making. The editorial board is committed to upholding high standards of scientific publishing and ensuring that all content published in the journal is of the highest quality.

Publisher Policies

The publisher of Cancer Studies and Molecular Medicine – Open Journal is dedicated to upholding the highest standards of scientific publishing. The journal adheres to ethical guidelines and practices, ensuring that all published content is accurate, reliable, and of high scientific value. Publisher policies include transparency in the peer review process, ensuring that manuscripts undergo rigorous evaluation by experts in the field. The publisher also ensures that all articles are freely available under the open-access model, allowing researchers from all over the world to access and disseminate knowledge. The publisher’s commitment to the integrity of the journal extends to ethical considerations in publishing, including the handling of conflicts of interest, research involving human and animal subjects, and data privacy. The publisher also takes measures to prevent misconduct, including plagiarism and unethical authorship practices. Additionally, the publisher is committed to providing continuous access to the journal’s archives through digital preservation services to ensure long-term accessibility of the published content. All policies are regularly reviewed and updated to comply with current best practices in scientific publishing.

COPE Recommendation for Conflict of Interest (specific to editors)

Cancer Studies and Molecular Medicine – Open Journal adheres to the COPE (Committee on Publication Ethics) guidelines regarding conflicts of interest (COI) for its editorial board. Editors must disclose any COI that may interfere with their editorial duties. If an editor has a financial, personal, or professional relationship with any author or institution involved in a manuscript under review, the editor is required to recuse themselves from the decision-making process. Editors are expected to evaluate submitted manuscripts based solely on their scientific quality and relevance to the journal, free from external influences. COI disclosures by editors are required upon their appointment and must be updated annually or whenever relevant changes occur. The journal is committed to ensuring transparency and impartiality in the editorial process, and editors must avoid any appearance of bias in their decisions. If necessary, the journal will appoint an independent editor or external reviewer to manage the review of a manuscript where a COI is present, in line with COPE’s recommendations. The adherence to COPE guidelines ensures that the journal maintains the highest standards of editorial integrity and impartiality.

Creative Commons License

All articles published in Cancer Studies and Molecular Medicine – Open Journal are made freely available under the Creative Commons Attribution (CC BY) license, unless otherwise specified. This open-access license allows others to freely share, reuse, and adapt the work, provided they give appropriate credit to the original authors. The CC BY license promotes the wide dissemination and impact of research by removing barriers to access, enabling the research to be used in subsequent academic and practical work. Authors retain the copyright to their work and are free to republish it in other venues, provided they comply with the terms of the Creative Commons license. The journal’s adoption of the Creative Commons license aligns with its commitment to open-access publishing and global knowledge-sharing, ensuring that all published research is accessible to the scientific community and the public.